1 and fi brillin-1 showed a mesangial distribution. An expansion of the LTBP-1 and fi brillin-1-positive mesangial area was seen on day 6 of disease, when transient matrix accumulation was most prominent. On day 12 of disease, glomerular LTBP-1 and fi brillin-1 immunoreactivities had returned to control levels. In serial sections, some colocalization of LTBP-1 and fi brillin-1 was detected in control as well as in nephritic glomeruli. Conclusion: Mesangial expression of LTBP-1 and fi brillin-1 is induced early in experimental nephritis and LTBP-1 and fi brillin-1 are partially colocalized in the nephritic glomerulus. An interaction of these molecules could stabilize latent TGF-␤ complexes and thus attenuate the activation of TGF-␤ during this self-limited glomerular disease. 
portant progression factor for glomerular diseases. We hypothesized that LTBP-1 and fi brillin-1 are coexpressed in the glomerulus and upregulated during glomerulonephritis. Methods: Acute anti-Thy1.1 glomerulonephritis was induced with a single intravenous injection (1 mg/kg body weight) of a monoclonal anti-Thy1.1 antibody in rats. Real-time RT-PCR and immunohistochemical analyses for LTBP-1 and fi brillin-1 were performed. Results: Induction of glomerular LTBP-1 mRNA was detected on day 2 of disease, while mRNA for fi brillin-1 was already upregulated 1 day after induction of disease. Both LTBP-e100 of the eye [2] . LTBP-1 and fi brillin-1 are highly homologous molecules and have been shown to colocalize and interact in the extracellular matrix of these tissues [3] . The interaction of LTBP-1 and fi brillin-1 seems to be important for the stabilization of latent TGF-␤ complexes in the extracellular matrix [4] . In fi brillin-1-defi cient mice, activation of TGF-␤ was recently described [5] . It is conceivable that the loss of fi brillin-1 destabilizes latent TGF-␤ complexes. In earlier studies, we have shown that glomerular mesangial cells express and secrete both LTBP-1 and fi brillin-1 in vitro [6] . Further, we and others have demonstrated an induction of TGF-␤ isoforms during experimental anti-Thy1.1 glomerulonephritis, which is characterized by transient mesangial hypercellularity and mesangial matrix expansion [7, 8] . We hypothesized that LTBP-1 and fi brillin-1 are coexpressed in the mesangial matrix and are upregulated during acute anti-Thy1.1 glomerulonephritis.
Methods

Experimental Disease
Male Sprague-Dawley rats (150-200 g) were obtained from Charles River Deutschland (Sulzfeld, Germany). Anti-Thy1.1 nephritis was induced by a single intravenous injection of 1 mg/kg body weight of anti-Thy1.1 antibody (ER4, Antibody Solutions, Palo Alto, Calif., USA) into the tail vein. Controls received solvent only. Four animals in each group were sacrifi ced on days 0, 1, 2, 3 and 5 (for mRNA analysis); and on days 0, 6 and 12 (for immunohistochemistry) after induction of nephritis. The kidneys were decapsulated and one kidney was used for isolation of glomeruli. The second kidney was embedded in paraffi n or processed for preparation of cryostat sections as described previously [7, 9] . For glomerular RNA isolation, glomeruli were isolated as described [7] .
Immunohistochemistry
Staining of cryostat or paraffi n sections was performed as described elsewhere [7] . The primary rabbit antibody to fi brillin-1 [10] was used at a dilution of 1: 500. The primary antibody to LTBP-1 (1: 250) was obtained from Pharmingen (Hamburg, Germany). CY3-labelled anti-rabbit IgG (DAKO Diagnostica, Hamburg, Germany) or secondary horseradish peroxidase-conjugated anti-rabbit IgG (Vectastain, Vector Lab, Burlingame, Calif., USA) were used as secondary antibodies. Glomerular fi brillin-1 and LTBP-1 staining was evaluated by densitometry using Metaview software. Staining was measured in every third glomerulus per cross-section of frozen kidney and was expressed as a percentage of stained area per glomerular tuft.
Isolation of mRNA and Real-Time PCR
To evaluate mRNA expression levels, total RNA was obtained from isolated glomeruli with RNeasy Mini columns (Quiagen, Hilden, Germany). Reverse transcription reactions and PCR were performed according to the manufacturer's instructions (Applied Biosystems, Weiterstadt, Germany) using SYBR green reagents. The relative amount of specifi c mRNA was normalized with respect to 18S rRNA. Primers used for amplifi cation of 18S cDNA were forward 5 TTGATTAAGTCCCTGCCCTTTGT3 and reverse 5 CGATCCGAGGGCCTCACTA3 . For amplifi cation of the rat fi brillin-1 cDNA, the forward primer was 5 TGCTCTGAAAG-GACCCAATGT3 and the reverse primer was 5 CGGGACAA-CAGTATGCGTTATAAC3 . For amplifi cation of the rat LTBP-1 cDNA the forward primer was 5 CGGATCCCCCTATGATC-TCA3 and the reverse primer was 5 TGACGAGGCGGTAGC-AGG3 . All samples were analyzed in triplicate.
Statistical Analyses
Two-way analysis of variance (ANOVA), followed by post hoc Newman-Keuls test with adjustment for multiple comparisons, was used to test signifi cance of differences between groups. A p value of ! 0.05 was considered signifi cant. The procedures were carried out using SPSS software (SPSS Inc., Chicago, Ill., USA). Values are displayed as means 8 standard error of the mean (SEM) for evaluation of fi brillin-1 and LTBP-1 mRNA expression and protein expansion.
Results
mRNA expression of fi brillin-1 and LTBP-1 was monitored from day 1 to day 5 of disease. Induction of antiThy1.1 glomerulonephritis led to an increase in fi brillin-1 and LTBP-1 mRNA levels after 1 or 2 days, respectively ( fi g. 1 A, B). Fibrillin-1 mRNA expression was increased fourfold by day 5, while LTBP-1 mRNA expression reached a twofold maximal increase on day 3 of disease ( fi g. 1 ). Fibrillin-1 and LTBP-1 protein deposition in the glomerular extracellular matrix was followed until day 12. In healthy glomeruli, fi brillin-1 and LTBP-1 were detected in areas consistent with a mesangial distribution ( fi g. 2 A, B) .
A marked expansion of fi brillin-1 and LTBP-1 immunoreactivity occurred on day 6 of disease ( fi g. 2 C, D) while on day 12 of disease the distribution of fi brillin-1 and LTBP-1 protein was comparable to that of healthy control glomeruli ( fi g. 2 E, F). Densitometric evaluation of glomerular fi brillin-1 staining during anti-Thy1.1 glomerulonephritis revealed a transient increase on day 6 (27.4 8 2.2% stained area/glomerulus on day 6 vs. 12.5 8 0.9% in controls, p ! 0.05, n = 7 per group), which corresponds to the stage of maximal glomerular hypercellularity and glomerulosclerosis [7] . By day 12 of this transient form of anti-Thy1.1 glomerulonephritis, glomeruli appear to be normal [7] . On day 12, densitometric evaluation showed that fi brillin-1 levels had almost reached the values of healthy glomeruli (16.9 8 1.4% stained area/ glomerulus, n = 6). Similar results were obtained for e101 LTBP-1 protein (36.0 8 3.4% stained area/glomerulus on day 6, vs. 16.7 8 1.1% in controls and 19.5 8 1.4% on day 12 of disease, p ! 0.05).
To test whether fi brillin-1 and LTBP-1 are colocalized, consecutive cryosections were stained for fi brillin-1 or LTBP-1 ( fi g. 3 ) . In healthy glomeruli, staining for fi brillin-1 was partially colocalized with the LTBP-1 staining ( fi g. 3 A, B) . On day 6 of disease, some colocalization of fi brillin-1 and LTBP-1 was also detected ( fi g. 3 C, D).
Discussion
Glomerular LTBP-1 and fi brillin-1 protein expression has been described previously in humans and rats [6] . We now demonstrate an induction of glomerular LTBP-1 and fi brillin-1 mRNA expression and protein expansion during experimental glomerulonephritis. mRNA expression of these molecules is induced soon after onset of the disease. Our results further reveal a colocalization, at least partial, of LTBP-1 and fi brillin-1 in the mesangial matrix.
The function of these two molecules in the glomerulus is not yet clear. Excessive deposition of LTBP-1 was detected in more severe forms of human IgA nephropathy [11] . Studies in cultured mesangial cells suggested that the activity of LTBP-1 contributes to the upregulation of mRNA expression of matrix molecules following mechanical stress [12] . Thus it seems possible that LTBP-1 is a progression factor, at least in chronic glomerular disease. A dual role for LTBP-1 is proposed [2] . On one hand, it serves as a structural matrix protein. On the other hand, it contributes to storage of latent TGF-␤ [2] and could thus regulate the activity of TGF-␤ by orchestrating effi cient secretion and correct folding of growth factors of the TGF-␤ family [1] .
In many tissues, fi brillin-1 is a component of elastic fi bers and acts as a template for elastin deposition [13] . In the mesangial matrix of the glomerulus, however, no elastin expression was found [6] . Thus, it remains unclear, as to whether fi brillin-1 has an elastic function in the glomerulus. Induction of fi brillin-1 was detected in kidney tissue in pressure-induced renal disease [14] , where it seemed to serve a protective role for the structure and function of the kidney. In this disease, most morphological alterations are seen in the tubulo-interstitium of the renal cortex (where elastin is abundant), and not in the glomeruli.
The coexpression of LTBP-1 and fi brillin-1 in the mesangial matrix and the partial overlap of the localization of both molecules argue for a cross-talk between LTBP-1 and fi brillin-1 in the glomerulus, although this does not necessarily imply a functional interaction. Isogai et al. [3] performed binding studies demonstrating that LTBP-1 and fi brillin-1 are able to interact on the molecular level. Some studies showing coexpression of LTBP-1 and fi brillin-1 exist: in a porcine model of coronary angioplasty, induction of LTBP-1 and fi brillin-1 expression and colocalization of both molecules were found in the neointima and adventitia [15] . Colocalization of LTBP-1 and fi brillin-1 was also described in pseudo-exfoliation syndrome of the eye [16] and in capsular opacifi cation [17] . Here, lens epithelial cells upregulate LTBP-1 and fi brillin-1 during postoperative healing. Our fi ndings in the glomerulus extend that obtained in other tissues to the renal mesangium and glomerular disease. Whether or not the induction of LTBP-1 and fi brillin-1 has a benefi cial effect for the course of anti-Thy1.1 glomerulonephritis is still unclear, but recent data suggest that the interaction of LTBP-1 and fi brillin-1 plays an important role in the regulation of TGF-␤ activation [4, 5] .
Mice defi cient in fi brillin-1 were developed as a model to study the pathology of Marfan syndrome [5] . In these mice, a dysregulation of TGF-␤ activation which contributed to the pathogenesis of typical features of the Marfan syndrome was found [4] . Thus, it seems conceivable that an impaired interaction between LTBP-1 and fi brillin-1 in fi brillin-1-defi cient mice leads to abnormal activation and signaling of TGF-␤ . Given the fact that TGF-␤ s are also transiently upregulated in acute anti-Thy1.1 glomerulonephritis [7] , one could speculate that in this model excessive TGF-␤ activity is scavenged by LTBP-1 and fi brillin-1 interactions, and this results in a self-limited pathological process in the affected glomeruli and a progression of the disease to a chronic state may be prevented. 
